Statins linked to less exercise, more diabetes

Share this article:

Statins are supposed to help protect hearts, but NPR reported Monday that a recent study shows that statin patients are less likely to be active than patients who don't take the cholesterol fighters. This is a bit of a problem, in that both exercise and statins can be part of a heart-healthy regimen.

NPR says researchers are not sure why patients may be moving less, and note the possibilities could include the sometimes-reported association between muscle pain and statin use, as well as the fact that patients may be taking it easier because statins are doing some of the work exercise did. The study found activity levels dropped the most in the first year of taking the medications, compared to before patients started the prescriptions.

Just how much of the drugs should be taken is also up for grabs—Reuters reported Monday that stroke and heart-attack patients taking high doses of statins—10mg or more of Crestor, 20mg or more of Lipitor, 40mg or more of Zocor—had a 15% greater risk of being diagnosed with diabetes than patients taking lower doses of these medications. Researchers are not clear why this is happening.

“This is not about stopping statins... the question is, should they be on a higher or lower dose?” lead researcher Colin Dormuth told Reuters.

Share this article:
You must be a registered member of MMM to post a comment.

Next Article in Business Briefs

Email Newsletters

MM&M Future Leaders

Register now

Early bird $1,950 before 31 October 2014

*Group discounts available on request 


Patient access to pharmaceuticals is a tale of two worlds—affordability has improved for the majority, while the minority is hampered by cost, distribution and red tape. To provide marketers with a well-rounded perspective, MM&M presents this e-book chock full of key insights. Click here to access it.

More in Business Briefs

Novartis said to be stepping out of HCV

Novartis is said to have relinquished rights to an investigational hep. C treatment, signaling its exit from the therapeutic space, according to a former partner's announcement.

Monday Moves: September 15

Hires and promotions for manufacturers, regulatory and agencies

Kantar acquires Evidências, expands Brazilian presence

The company's acquisition signals the growing importance of understanding the Brazilian healthcare market and evidence-based healthcare management services.